Drug
Oglemilast
Oglemilast is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
4
100%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 24 (100.0%)
Trials by Status
unknown125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00671073
completedphase_2
Study of Oglemilast for the Prevention of Asthma.
NCT00322283
completedphase_2
Study of Oglemilast for the Treatment of Asthma
NCT00322686
unknownphase_2
A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma
NCT00859404
Clinical Trials (4)
Showing 4 of 4 trials
NCT00671073Phase 2
Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00322283Phase 2
Study of Oglemilast for the Prevention of Asthma.
NCT00322686Phase 2
Study of Oglemilast for the Treatment of Asthma
NCT00859404Phase 2
A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4